Medical Researches
Possibly Effective
Based on 37 Researches
We conducted a study to see if giving probiotics to mothers during pregnancy and breastfeeding could help reduce eczema in infants at risk. This double-blind, placebo-controlled trial involved 241 mother-infant pairs, where mothers were given either specific probiotics or a placebo.
Our findings showed that infants whose mothers took Lactobacillus rhamnosus and Bifidobacterium longum had a significantly lower risk of developing eczema in their first two years. This suggests that probiotics can be a safe and effective preventive measure for high-risk infants.
Read More
Probiotics reduce infant eczema riskMaternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant.
High relevance for eczema prevention
We studied whether giving probiotics to expecting and breastfeeding mothers could help lower the risk of eczema in their infants. In a well-structured trial, 241 mother-infant pairs participated, with some mothers receiving probiotics and others receiving a placebo.
Over two years, we found that infants born to mothers who took Bifidobacterium longum and other probiotics had a significantly reduced risk of developing eczema. This approach appeared safe, with no reported adverse effects, although probiotics did not impact atopic sensitization rates.
Read More
We explored the potential of Lactobacillus acidophilus KBL409 in addressing atopic dermatitis, a common form of eczema. By using a mouse model induced by house dust mites, we found that administering this probiotic led to significantly lower dermatitis scores and less immune cell infiltration in the skin.
Additionally, L. acidophilus KBL409 reduced serum immunoglobulin E and influenced various cytokines linked to inflammation. It also positively affected gut microbiota and concentrations of beneficial compounds, hinting at a broader impact on our immune responses. Overall, our findings suggest that L. acidophilus KBL409 may be a promising probiotic for eczema management.
Read More
We conducted a thorough investigation on the effects of Lactobacillus acidophilus L-92 in adults with atopic dermatitis.
In a placebo-controlled, double-blinded study, we observed 50 patients who consumed either L-92 or a placebo for 24 weeks.
Results showed that those taking L-92 had notable improvements in skin symptoms over time, including reduced severity and incidents of scratching.
Overall, the findings suggest that L-92 might play a beneficial role in managing eczema symptoms.
Read More
Probiotic reduces eczema prevalenceEarly supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?
High relevance to eczema prevention
We explored the potential of Lactobacillus rhamnosus HN001 in reducing eczema among infants at high risk. Through a robust double-blind trial, expecting mothers took the probiotic from 35 weeks pregnant and continued while breastfeeding, while infants received it from birth to two years. Remarkably, this approach halved the prevalence of eczema by ages 2 and 4. Even better, the benefits seemed to last until age 6, showing promising potential in preventing eczema and associated allergic sensitization. However, another probiotic, HN019, did not show similar effects, suggesting specific benefits tied to HN001.
Read More
User Reviews
Cured eczema. My 6-year-old had very itchy eczema spots. A friend recommended this product, and it worked wonders! His skin is completely clear, and he no longer complains about itchiness. I'll definitely return as a customer!
Eczema relief. My son has severe eczema. We've tried everything and seen multiple doctors. While these didn’t completely clear it, they definitely helped. His skin is clearer now, and he has relief. I would recommend this product.